Does Timing of Ventricular Tachycardia Ablation Affect Prognosis in Patients With an Implantable Cardioverter Defibrillator? Results From the Multicenter Randomized PARTITA Trial

医学 心脏病学 四分位间距 内科学 室性心动过速 植入式心律转复除颤器 临床终点 危险系数 多中心试验 随机对照试验 休克(循环) 烧蚀 心动过速 导管消融 置信区间 多中心研究
作者
Paolo Emilio Della Bella,Francesca Baratto,Pasquale Vergara,Patrizia Bertocchi,Matteo Santamaria,Pasquale Notarstefano,Leonardo Calò,Daniela Orsida,Luca Tomasi,Marcello Piacenti,Stefano Sangiorgio,Francesco Pentimalli,Etienne J. Pruvot,João de Sousa,Frédéric Sacher,Massimo Vito Tritto,Luca Rebellato,Thomas Deneke,Salvo Andrea Romano,Martina Nesti
出处
期刊:Circulation [Lippincott Williams & Wilkins]
卷期号:145 (25): 1829-1838 被引量:216
标识
DOI:10.1161/circulationaha.122.059598
摘要

Background: Optimal timing for catheter ablation of ventricular tachycardia is an important unresolved issue. There are no randomized trials evaluating the benefit of ablation after the first implantable cardioverter defibrillator (ICD) shock. Methods: We conducted a 2-phase, prospective, multicenter, randomized clinical trial. Patients with ischemic or nonischemic dilated cardiomyopathy and primary or secondary prevention indication for ICD were enrolled in an initial observational phase until first appropriate shock (phase A). After reconsenting, patients were randomly assigned 1:1 in phase B to immediate ablation (within 2 months from shock delivery) or continuation of standard therapy. The primary end point was a composite of death from any cause or hospitalization for worsening heart failure. Amiodarone intake was not allowed except for documented atrial tachyarrhythmias. On July 23, 2021, phase B of the trial was interrupted as a result of the first interim analysis on the basis of the Bayesian adaptive design. Results: Of the 517 patients enrolled in phase A, 154 (30%) had ventricular tachycardia, 56 (11%) received an appropriate shock over a median follow-up of 2.4 years (interquartile range, 1.4–4.4), and 47 of 56 (84%) agreed to participate in phase B. After 24.2 (8.5–24.4) months, the primary end point occurred in 1 of 23 (4%) patients in the ablation group and 10 of 24 (42%) patients in the control group (hazard ratio, 0.11 [95% CI, 0.01–0.85]; P =0.034). The results met the prespecified termination criterion of >99% Bayesian posterior probability of superiority of treatment over standard therapy. No deaths were observed in the ablation group versus 8 deaths (33%) in the control group ( P =0.004); there was 1 worsening heart failure hospitalization in the ablation group (4%) versus 4 in the control group (17%; P =0.159). ICD shocks were less frequent in the ablation group (9%) than in the control group (42%; P =0.039). Conclusions: Ventricular tachycardia ablation after first appropriate shock was associated with a reduced risk of the combined death or worsening heart failure hospitalization end point, lower mortality, and fewer ICD shocks. These findings provide support for considering ventricular tachycardia ablation after the first ICD shock. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT01547208.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
eeven完成签到 ,获得积分10
刚刚
h11完成签到 ,获得积分10
1秒前
laber给36hours的求助进行了留言
3秒前
自由如风完成签到 ,获得积分10
3秒前
壮壮学长完成签到 ,获得积分10
4秒前
Jiang完成签到,获得积分10
4秒前
yjy完成签到,获得积分10
6秒前
淡淡完成签到 ,获得积分10
11秒前
hongjian539完成签到 ,获得积分10
12秒前
Jane完成签到 ,获得积分10
13秒前
雪山大地发布了新的文献求助10
14秒前
危机的冬瓜完成签到,获得积分10
16秒前
人间一两风完成签到 ,获得积分10
16秒前
抗体药物偶联完成签到,获得积分10
17秒前
可耐的万言完成签到 ,获得积分10
17秒前
17秒前
超帅的又槐完成签到,获得积分10
18秒前
赵慧芳完成签到 ,获得积分10
19秒前
HJJHJH的应助被科研通管家采纳,获得30
21秒前
HJJHJH的应助被科研通管家采纳,获得30
22秒前
Auster发布了新的文献求助10
22秒前
leftarrow完成签到,获得积分10
24秒前
啊哒吸哇完成签到,获得积分0
28秒前
cly完成签到 ,获得积分10
28秒前
小胖子完成签到 ,获得积分10
29秒前
合适的绿柏完成签到,获得积分10
29秒前
aberner完成签到 ,获得积分10
30秒前
Hello的应助被369ninja采纳,获得30
30秒前
大大怪完成签到,获得积分10
36秒前
38秒前
飞哥与小佛完成签到,获得积分10
39秒前
乐乐的应助被王勾勾采纳,获得10
39秒前
macrossfev完成签到,获得积分10
39秒前
活泼雪莲发布了新的文献求助10
44秒前
save完成签到,获得积分10
45秒前
柠檬普洱茶完成签到,获得积分10
51秒前
安静怜雪完成签到,获得积分10
53秒前
Cosmosurfer完成签到,获得积分0
55秒前
观澜完成签到 ,获得积分10
55秒前
mousfy完成签到 ,获得积分10
58秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Hidden Empire of Finance: How Wall Street Profits from Our Cities and Fuels Global Inequality 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8166550
求助须知:如何正确求助?哪些是违规求助? 9559535
关于积分的说明 21750720
捐赠科研通 7757357
什么是DOI,文献DOI怎么找? 3429141
关于科研通互助平台的介绍 2553523
邀请新用户注册赠送积分活动 2473904